| Financial Year |
March 31 2023 |
| Monetary Funds |
1,121,089,758.17 |
| Held-for-trading Financial Assets |
4,238,686.21 |
| Notes Receivable |
110,000.00 |
| Accounts Receivable |
1,886,474.60 |
| Advances to Suppliers |
1,050,198.46 |
| Other Receivables |
6,569,175.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
66,167,084.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
302,751,204.45 |
| Total Current Assets |
1,503,862,581.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
123,383,526.54 |
| Fixed Assetes |
641,228,576.65 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
177,339,465.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,685,568.01 |
| Deferred Income Tax Assets |
37,113,309.76 |
| Other Non-Current Assets |
701,900.00 |
| Sub-Total of Non-Current Assets |
1,011,556,241.53 |
| Total Assets |
2,515,418,823.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
196,210,148.17 |
| Accounts Received In Advance |
2,366,194.29 |
| Employee Compensation Payable |
49,510,310.07 |
| Taxes Payable |
13,251,812.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
255,874,510.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,956,058.84 |
| Other Current Liabilities |
32,722,285.89 |
| Sub-Total of Current Liabilities |
632,373,712.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
122,151,485.72 |
| Total Liabilities |
754,525,198.59 |
| Paid-In Capital(Or Share Stock) |
415,718,940.00 |
| Capital Surplus |
180,005,059.01 |
| Surplus Reserve |
193,761,019.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
953,999,380.55 |
| Minority Stockholder's Interest |
1,030,285.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,759,863,339.26 |
| Owner's Equity（Stockholder's Equity） |
1,760,893,624.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,515,418,823.28 |
